PKPiotr Kupidłowski

Piotr Kupidłowski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Piotr Kupidłowski has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    POTENTIAL EFFECTS OF BOVINE COLOSTRUM IN PREVENTION OF NECROTIZING ENTEROCOLITIS: A REVIEW

    by Aleksandra Przybylska, Julia Ciechanowicz, Stanisław Ciechanowicz, Julia Dura, Marika Gutowska, Piotr Kupidłowski, Agata Nowacka, Adrianna Perzanowska, Zuzanna Tomaszewska, Anna Zielińska

    Objectives: Necrotizing enterocolitis is a critical gastrointestinal disorder predominantly affecting neonates. Bovine colostrum is a nutrient-dense first secretion from cows postpartum. Bovine colostrum is abundant in immunoglobulins, antimicrobial peptides as well as growth factors, making it a promising candidate for nutritional intervention for necrotizing enterocolitis. This review aims to critically assess the existing preclinical and clinical evidence on the efficacy of bovine colostrum supplementation in reducing the incidence and severity of necrotizing enterocolitis in neonatal populations. Methods: A literature search was conducted using PubMed and Scopus databases. Relevant animal trials and human randomized controlled trials evaluating the impact of bovine colostrum on necrotizing enterocolitis incidence and severity were analysed. Key findings: Preclinical studies in neonatal piglet models consistently demonstrate that bovine colostrum reduced the incidence and severity of necrotizing enterocolitis compared to infant formula, with mechanisms involving enhanced gut barrier integrity, microbiota modulation and reduction in inflammation. Bovine colostrum outcomes were often comparable or superior to human donor milk. However, recent randomised controlled trials in preterm human infants have not shown a statistically significant reductions in necrotizing enterocolitis incidences with bovine colostrum supplementation, possibly due to differences in product processing, dosage and open-label study designs. Conclusions: Despite promising outcomes in zootechnical models, current clinical evidence does not confirm efficacy of bovine colostrum in necrotizing enterocolitis prevention in human neonates. Further high-quality, standardized, double-blinded clinical trials are needed to clarify its potential in infant care.

  • Open Access

    PROBIOTIC SUPPLEMENTATION IN NEONATAL JAUNDICE: CURRENT PERSPECTIVES AND THERAPEUTIC POTENTIAL

    by Anna Zielińska, Agata Nowacka, Marika Gutowska, Zuzanna Tomaszewska, Julia Ciechanowicz, Aleksandra Przybylska, Stanisław Ciechanowicz, Piotr Kupidłowski, Adrianna Maria Perzanowska, Julia Dura

    Objective: The objective of this paper is to review the adjunctive role of probiotics in the treatment of neonatal jaundice (NJ), focusing on mechanisms, clinical trial evidence, and synergy with phototherapy. Methods: Narrative synthesis of randomized controlled trials, mechanistic studies, and meta-analyses of probiotic interventions in term and preterm infants with hyperbilirubinemia. Results: Probiotics, especially Saccharomyces boulardii and Bifidobacterium animalis subsp. lactis CP 9 enhance bilirubin clearance via gut modulation, decreased β glucuronidase activity, improved motility, and strengthened barrier integrity. Clinical trials report faster bilirubin decline, shorter phototherapy time, and better feeding tolerance. Multi-strain products also show positive outcomes, though variability in strains and dosing persists. Conclusions: Probiotics are safe and effective adjuncts to phototherapy in treating NJ. Future standardized large RCTs with long-term follow-up are necessary to define precise clinical guidelines.

  • Open Access

    VULVAR LICHEN SCLEROSUS IN WOMEN - THE IMPACT ON QUALITY OF LIFE, SEXUAL AND MENTAL HEALTH

    by Agata Nowacka, Marika Gutowska, Zuzanna Tomaszewska, Anna Zielińska, Julia Ciechanowicz, Aleksandra Przybylska, Stanisław Ciechanowicz, Piotr Kupidłowski, Adrianna Perzanowska, Julia Dura

    Objective: Vulvar Lichen Sclerosus (VLS) is a chronic, inflammatory dermatosis that affects women. Physical symptoms and their treatment are well-documented, while the psychological impact requires further research. This review aims to summarize the current state of knowledge about quality of life, sexual health, and mental health amongst women with VLS. Methods: PubMed and ScienceDirect were systematically searched for studies published between 2014 and 2024. Inclusion criteria focused on original research assessing quality of life, sexual function, depression, or anxiety in women diagnosed with VLS. Studies not in English or Polish, lacking full-text availability, or without original data were excluded. Data was extracted and synthesized narratively. Key Findings: Vulvar lichen sclerosus (VLS) significantly affects women’s quality of life, particularly in domains related to sexual and psychological well-being. Common challenges include diminished self-worth, decreased relationship satisfaction, and a higher presence of depressive symptoms. Anxiety is also frequently reported. In the most advanced cases, patients declared suicidal ideation. Women with VLS experience feelings of isolation and shame, often turning to online forums for information and emotional support. Conclusion: VLS has an impact on psychological and sexual function, mental health, and quality of life. This review emphasizes the importance of recognizing and addressing psychological impairments in conjunction with physical symptoms and the need for a multidisciplinary strategy in the management of VLS. Further research needs to focus on the psychological and sexual aspects of lichen sclerosus in women.

  • Open Access

    EVOLVING CERVICAL CANCER SCREENING GUIDELINES AND HPV VACCINATION STATUS. A LITERATURE REVIEW

    by Zuzanna Tomaszewska, Adrianna Perzanowska, Anna Zielińska, Agata Nowacka, Julia Ciechanowicz, Stanisław Ciechanowicz, Julia Dura, Marika Gutowska, Piotr Kupidłowski, Aleksandra Przybylska

    Background: Persistent infection with high-risk types of human papillomavirus is the primary cause of cervical cancer globally. Recent decades have witnessed significant advances in prevention, with the introduction of effective prophylactic HPV vaccines and highly sensitive molecular screening methods transforming how cervical cancer is detected and managed. Aim of this review is to explore the impact of HPV vaccination programs on cervical cancer prevention strategies, focusing on how vaccination coverage influences the global shift from traditional cytology-based screening to HPV DNA testing in selected high-income countries. Methodology: A comprehensive search was conducted across scientific databases, including PubMed, the Cochrane Library, and WHO reports, focusing on recent peer-reviewed studies. Results: The diagnostic performance of cytology has declined in vaccinated populations due to fewer abnormal findings, prompting a shift toward primary HPV DNA testing. This method offers sensitivity rates exceeding 90% and supports longer screening intervals of five years or more. Countries like Australia, the Netherlands, Sweden, and the UK have adopted nationwide HPV-based screening, while Poland initiated pilot HPV testing programs in 2024. However, several barriers persist, including disparities in vaccine distribution, the high cost of molecular diagnostics, and persistent public hesitancy toward vaccination. Conclusions: Combining widespread HPV vaccination with HPV DNA-based screening offers the most promising strategy for reducing cervical cancer incidence and achieving the WHO's 2030 elimination targets. Those recommendations include expanding gender-neutral vaccination, supporting transitions to HPV testing in lagging regions, and incorporating innovations like self-sampling to improve outreach and screening participation.

  • Open Access

    NUTRITIONAL AND LIFESTYLE DETERMINANTS IN THE PATHOGENESIS AND PROGRESSION OF AGE-RELATED MACULAR DEGENERATION

    by Piotr Kupidłowski, Julia Ciechanowicz, Stanisław Ciechanowicz, Julia Dura, Marika Gutowska, Agata Nowacka, Adrianna Perzanowska, Aleksandra Przybylska, Zuzanna Tomaszewska, Anna Zielińska

    Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the elderly, with its global prevalence expected to rise substantially in the coming decades. Given its multifactorial pathogenesis—driven by oxidative stress, retinal pigment epithelium (RPE) dysfunction, and chronic inflammation—identifying modifiable nutritional and lifestyle risk factors has become a central focus in developing preventive strategies. This review article synthesizes current literature retrieved from PubMed and Google Scholar to examine the influence of dietary fatty acids, antioxidants, smoking, and alcohol consumption on the onset and progression of AMD. Key sources include large-scale observational cohorts and randomized controlled trials, notably AREDS and AREDS2. Long-chain omega-3 polyunsaturated fatty acids (PUFAs), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), primarily obtained from fish, show consistent protective effects against both early and late AMD. In contrast, excessive omega-6 intake and an unfavorable omega-6 to omega-3 ratio may promote retinal inflammation. Antioxidants and zinc significantly reduce the risk of disease progression, particularly in individuals with intermediate AMD. Lutein and zeaxanthin offer additional benefits. Smoking is one of the strongest modifiable risk factors, with persistent effects even after cessation. Moderate to heavy alcohol consumption correlates with early-stage AMD. Robust evidence supports the implementation of public health strategies focused on smoking cessation, reducing alcohol intake, and promoting nutrient-rich diets to lower AMD incidence and progression. Integrating nutritional counseling into routine ophthalmologic care represents a biologically plausible and cost-effective approach to preserving vision and improving long-term outcomes in at-risk populations.

  • Open Access

    THE IMPACT OF SOY ON CANCER RISK AND OUTCOMES

    by Stanisław Ciechanowicz, Julia Ciechanowicz, Julia Dura, Marika Gutowska, Piotr Kupidłowski, Agata Nowacka, Adrianna Perzanowska, Aleksandra Przybylska, Zuzanna Tomaszewska, Anna Zielińska

    Aim: Soy consumption is growing globally, bringing attention to its health effects. This review aims to summarize current knowledge about the impact of soy on the risk and outcomes of various cancers. Methods: The study is based on meta-analysis, randomized controlled trials, and systematic reviews from the PubMed database published over the past 15 years. Key findings and Conclusions: Existing literature indicates significant health benefits associated with soy intake in the prevention of breast and prostate cancer. Studies provide moderate to weak evidence for an inverse association between soy intake and the risk of gastric, gastrointestinal, colorectal, endometrial and lung cancers. No significant relationship has been identified between soy supplementation and the risk of ovarian cancer, bladder cancer and leukemia. The exact mechanisms responsible for the anticancer properties of soy remain unknow and available research is characterized by high heterogeneity. Therefore, there is a need for larger studies concentrating on specific soy compounds.

  • Open Access

    ENDOMETRIOSIS AND VTE: A REVIEW OF THE EVIDENCE AND PATHOPHYSIOLOGICAL MECHANISMS

    by Julia Dura, Julia Ciechanowicz, Stanisław Ciechanowicz, Marika Gutowska, Piotr Kupidłowski, Agata Nowacka, Adrianna Perzanowska, Aleksandra Przybylska, Zuzanna Tomaszewska, Anna Zielińska

    Introduction and objective: Endometriosis is a chronic inflammatory condition affecting approximately 10% of women of reproductive age. Venous thromboembolism (VTE) is a major cause of mortality worldwide. Because the relationship between endometriosis and VTE is not well-defined, we conducted a review of studies that assessed the occurrence of VTE in women with endometriosis. Review methods: A structured PubMed search was conducted to identify studies published between January 2015 and April 2025 assessing the risk of VTE in patients with endometriosis. Seven studies met the inclusion criteria after screening for relevance and exclusion of case reports. Abbreviated description of the state of knowledge: Some large-scale studies suggest an elevated VTE risk in women with endometriosis, particularly in younger individuals, during pregnancy, or when using hormonal therapy. However, results vary due to differences in study design, diagnostic definitions, and confounder adjustment. Pathophysiologically, endometriosis-related inflammation, hormonal influences, and endothelial dysfunction may contribute to a prothrombotic state. Summary: The association between endometriosis and VTE remains unclear; biologically plausible mechanisms and clinical patterns suggest it may be relevant in certain populations. Future research should focus on well-characterized, prospective studies. Clinicians should remain alert to thrombotic risk in women with endometriosis, especially when additional risk factors are present.

  • Open Access

    PERTUSSIS- EPIDEMIOLOGY, DIAGNOSTICS, TREATMENT. LITERATURE REVIEW

    by Adrianna Perzanowska, Zuzanna Tomaszewska, Anna Zielińska, Julia Ciechanowicz, Stanisław Ciechanowicz, Julia Dura, Marika Gutowska, Piotr Kupidłowski, Agata Nowacka, Aleksandra Przybylska

    Introduction and purpose. The bacterium Bordetella pertussis causes pertussis, an infectious respiratory disease. Despite the introduction of an expanded vaccination programme over the past decades, pertussis remains a public health concern. This literature review aims to compare clinical and laboratory diagnostics. Additionally, we will focus on the impact of the Covid-19 pandemic on the increase in cases of the disease. State of knowledge. The illness has three phases: an initial stage lasting one to two weeks; a second stage characterised by coughing fits lasting up to four weeks; and a final recovery phase. Although antibiotics used during the second stage reduce infectiousness, it is unclear whether they reduce the duration of illness. During the first two weeks, patients may experience flu-like symptoms. Culture testing is considered the gold standard, providing 100% specificity. This enables identification of the strain and antibiotic susceptibility testing. This method is most effective within the first two weeks of illness, while viable bacteria are still present.The number of cases fluctuates from year to year, but there has been a marked decrease among young children and an increase among adolescents and adults. Following the discontinuation of protective measures against SARS-CoV-2, significant pertussis outbreaks have occurred. Material and methods. This review analyzes the epidemiology, diagnosis, and treatment of whooping cough, with a particular focus on the years from 2019 to the present. The article was based on sources from scientific databases such as PubMed. Summary. Researchers have linked the increase in pertussis cases in recent years to the lifting of restrictions during the post-Covid period. It is therefore important to raise public awareness of the need for revaccination and to continue scientific research into the epidemiology and diagnosis of this disease.